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NMDA receptors interact via the extended intracellular
C-terminal domain of the NR2 subunits with constituents of the
postsynaptic density for purposes of retention, clustering, and
functional regulation at central excitatory synapses. To examine
the role of the C-terminal domain of NR2A in the synaptic
localization and function of NR2A-containing NMDA receptors
in hippocampal Schaffer collateral–CA1 pyramidal cell syn-
apses, we analyzed mice which express NR2A only in its
C-terminally truncated form. In CA1 cell somata, the levels,
activation, and deactivation kinetics of extrasynaptic NMDA
receptor channels were comparable in wild-type and mutant
NR2AD C/ D C mice. At CA1 cell synapses, however, the trun-
cated receptors were less concentrated than their full-length
counterparts, as indicated by immunodetection in cultured neu-
rons, synaptosomes, and postsynaptic densities. In the mutant,
the NMDA component of evoked EPSCs was reduced in a
developmentally progressing manner and was even more re-
duced in miniature EPSCs (mEPSCs) elicited by spontaneous
glutamate release. Moreover, pharmacologically isolated
NMDA currents evoked by synaptic stimulation had longer
latencies and displayed slower rise and decay times, even in
the presence of an NR2B-specific antagonist. These data
strongly suggest that the C-terminal domain of NR2A subunits
is important for the precise synaptic arrangement of NMDA
receptors.
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NMDA receptors are critical players in excitatory synaptic trans-
mission as well as in synaptic plasticity, which may underlie
memory acquisition and recall (Bliss and Collingridge, 1993).
Several NMDA receptor subtypes exist, defined by the particular
NR2 subunits that assemble with the principal NR1 subunit. The
NR2 subunits impart on receptor channels distinct kinetic, gat-
ing, divalent ion block, ion permeation, and pharmacological
properties (Hollmann and Heinemann, 1994; McBain and Mayer,
1994; Dingledine et al., 1999). Furthermore, they possess ex-
tended intracellular C-terminal domains by which they interact
with diverse proteins of the postsynaptic density (PSD) for pur-
poses of synaptic localization, clustering, and signal transduction
(Sheng, 1996; Kennedy, 1997, 1998; Kornau et al., 1997; Kim and
Huganir, 1999).
The importance of the C termini of NMDA receptor subunits
is further emphasized by NR2D C/ D C mice expressing
C-terminally truncated NR2 subunits (Sprengel et al., 1998),
which phenotypically resemble the respective NR2 knockout
mice. Mice expressing C-terminally truncated NR2BDC subunits
died perinatally (Mori et al., 1998; Sprengel et al., 1998), whereas
mice expressing C-terminally truncated NR2ADC subunits were
ataxic and failed to develop long-term potentiation (LTP) (Spren-
gel et al., 1998). The protein level of NR2DC subunits in total
brain appeared normal (Mori et al., 1998; Sprengel et al., 1998).
Thus, the most likely explanation for the correspondence in
phenotype of mice expressing a C-terminally truncated NR2
subunit, or not expressing the NR2 subunit at all, was that
absence of the C-terminal tail prevented the proper linkage of
synaptic NMDA receptors to signal transduction pathways, thus
amounting to a lack of NMDA receptor function (Sprengel et al.,
1998). In addition, Mori and colleagues (1998) found a greatly
reduced contribution of NR2BDC subunits at perinatal hip-
pocampal CA1 synapses.
CA1 neurons from adult animals express NMDA receptors
containing NR2A and/or NR2B subunits. Their relative contri-
bution to synaptic transmission and plasticity is unclear and may
result from distinct regulation by intracellular signaling molecules
and/or differential subcellular localization. The C-terminal tails
of NR2A and NR2B are potential targets for tyrosine kinases,
CaM kinase II, and protein kinases A and C (Moon et al., 1994;
Wang and Salter, 1994; Ko¨hr and Seeburg, 1996; Omkumar et al.,
1996; Leonard and Hell, 1997; Tingley et al., 1997). The regula-
tion of NMDA receptor activity can be caused by a direct phos-
phorylation of receptor protein or may involve the phosphoryla-
tion of associated postsynaptic proteins (Zheng et al., 1999).
Although in cultured neurons NMDA receptors containing
NR2A localize preferentially at synaptic sites and NMDA recep-
tors containing NR2B subunits can also localize extrasynaptically
(Li et al., 1998; Tovar and Westbrook, 1999), both NR2A- and
NR2B-containing receptors are activated by Schaffer collateral
stimulation in hippocampal slices of adult mice (Kirson and
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Yaari, 1996), consistent with the presence of both NR2A and
NR2B subunits in postsynaptic densities (Kennedy, 1997, 1998).
We have studied NR2AD C/ D C mice by immunocytochemistry,
biochemistry, and electrophysiology. We found a reduced number
of synaptic NR2ADC-containing NMDA receptors compared
with wild type, although the number of somatic, i.e., extrasynaptic
mutant receptors appeared unchanged. In addition, the slower
kinetic properties of evoked synaptic NMDA receptor currents in
the mutants suggest that the truncated mutant receptors are
located, on average, farther from release sites than wild-type
receptors.
MATERIALS AND METHODS
Immunocytochemistry. Cultures of mouse hippocampal neurons (embry-
onic day 16) were grown as described (Brewer et al., 1993) from 10
wild-type and 11 NR2A D C/ D C embryos. After 21 d in vitro, cultures were
fixed and labeled (Kornau et al., 1995) with an affinity-purified rabbit
antiserum raised against an N-terminal epitope of NR2A (8.5 mg/ml).
Cultures from 14 embryos were labeled in parallel with anti-NR2B
C-terminal rabbit antiserum diluted 1:300 (Kornau et al., 1995). Cultures
from one wild-type and two mutant embryos were double-labeled with
anti-NR2A or anti-NR2B, respectively, and mouse anti-synapsin I (1:
250; Chemicon, Temecula, CA) antibodies. After incubation with sec-
ondary antibodies (Alexa 488-conjugated goat anti-rabbit IgG and Alexa
568-conjugated goat anti-mouse IgG; Molecular Probes, Eugene, OR),
8–22 individual neurons per embryo were selected under phase optics,
then imaged confocally (Zeiss LSM 310) at identical contrast and bright-
ness settings.
Images for computer analysis were chosen based on normal morpho-
logical appearance of pyramidal neurons, independent of their staining
patterns. Dendrites were selected in Adobe Photoshop 5.0.2, and their
length was measured using Canvas 5.0 (Daneba Systems). In NIH Image
1.62 (developed at National Institutes of Health and available on the
Internet at http://rsb.info.nih.gov/nih-image/), pictures were inverted and
an identical threshold intensity (130) was set to automatically analyze
intensity, area, and number of the clusters. For background analysis
(pixels below threshold), a “density slice” range was set from 254 to 130.
Neither background intensity nor cluster staining intensity differed be-
tween genotypes (background, NR2A: wild type, 36 6 1, n 5 12; mutant,
33 6 1, n 5 12; NR2B: wild type, 39 6 1, n 5 6; mutant, 36 6 2, n 5 6;
cluster intensity, NR2A: wild type, 163 6 2, n 5 12; mutant, 157 6 1, n 5
12: NR2B, wild type, 170 6 9, n 5 6; mutant, 183 6 5, n 5 6).
Western blot analysis. Homogenates, synaptosomes, and PSD fractions
were prepared as described (Carlin et al., 1980) from postnatal day 30
(P30) mouse forebrains (PSD fraction of mutants in NR2A blot, P42)
except that the Triton X-100-treated synaptosomes were not purified on
a second sucrose density gradient but were centrifuged (1 hr, 70,000 3 g)
to obtain the PSD fraction. For synaptosomes and PSD preparations,
eight brains (for homogenates, two brains) were pooled and homoge-
nized. Protein concentration was determined by a Lowry assay after
deoxycholic acid-trichloroacetic acid precipitation.
Proteins were separated by 10% SDS-PAGE (for NR2A) or 8%
SDS-PAGE (for NR1 and NR2B) and blotted onto nitrocellulose mem-
branes (BA 85, Schleicher & Schuell) using a wet transfer device. Pri-
mary antibodies and dilutions were the following: mouse monoclonal,
N-terminal anti-NR2A, 1:500 (2H9.24A6, Boehringer Mannheim, Mann-
heim, Germany); rabbit polyclonal, C-terminal anti-NR2B, 1:20000 (see
above); rabbit polyclonal, C-terminal anti-NR1, 1:300 (Chemicon). Sig-
nals were generated by alkaline phosphatase with appropriate species-
matched secondary antibodies (anti-mouse, Boehringer Mannheim; anti-
rabbit, Jackson ImmunoResearch, West Grove PA). Immunoblots were
scanned and signals were quantified in Image Gauge 3.0. To document
specific enrichment of PSD protein complexes, an antibody against a
cytosolic protein was applied (rabbit polyclonal anti-Dendrin, crude
bleed, 1:2000). Dendrin was present in homogenates, reduced in synap-
tosomes, but undetectable in PSDs (data not shown).
Electrophysiology. Transverse hippocampal slices (250 mm) were cut
from brains of 13- to 15-d-old (P15) and 28- to 30-d-old (P30) C57BL6
wild-type and NR2A D C/ D C mice. CA1 pyramidal cells were identified by
infrared differential interference contrast microscopy (Stuart et al.,
1993). All measurements were performed at room temperature (22°C)
using an EPC-9 amplifier (HEKA Elektronik). Somatic recordings were
performed with a piezo-controlled fast application system (solution ex-
change time, measured with an open patch pipette, was 100–200 msec) to
activate nucleated whole-soma patches in solution containing (in mM):
135 NaCl, 5.4 KCl, 1.8 CaCl2, 5 HEPES, pH 7.25, NaOH. The intracel-
lular solution consisted of (in mM): 140 CsCl, 2 MgCl2, 2 Na2-ATP, 10
EGTA, 10 HEPES, pH 7.25, CsOH. AMPA or NMDA receptor cur-
rents were activated by glutamate (1 mM; 10 or 50 msec application) in
the presence of AP5 (30 mM, Tocris, Ballwin, MO) or NBQX (5 mM,
Tocris), glycine (10 mM, Sigma, St. Louis, MO) and 0 mM Mg 21 from
2100 mV to 1100 mV in 20 mV increments. The ratio of NMDA/
AMPA receptor currents was derived from the peaks recorded at 240
mV and 280 mV. Desensitization was investigated at 280 mV and 180
mV using 400 msec glutamate pulses, and the recovery from desensiti-
zation was investigated by 50 msec pulses at 280 mV using a paired-pulse
protocol.
For synaptic currents, the recording chamber was perfused with an
extracellular low Mg 21 solution (Ringer’s) consisting of (in mM): 125
NaCl, 2.5 KCl, 25 glucose, 25 NaHCO3, 1.25 NaH2PO4, 2 CaCl2, 0.1
MgCl2, 0.01 bicuculline (Sigma), and 0.01 glycine, continuously bubbled
with 5% CO2–95% O2. Intracellular solution for EPSC recordings con-
tained (in mM): 125 Cs-gluconate, 20 CsCl, 10 NaCl, 10 HEPES, 0.2
EGTA, 4 ATP-Mg, 0.3 GTP-Na, and 2.5 QX-314 (Calbiochem, La Jolla
CA), pH 7.25, CsOH. Pipette resistance was 3–5 MV. A bipolar tungsten
electrode was placed in the stratum radiatum to stimulate at 0.05 Hz.
Series resistance compensation was set to 60–90% in whole-cell config-
uration. To monitor series resistance, a 5 mV hyperpolarizing voltage
step was applied before each stimulation, and cells with changes .15%
were discarded. The amplitudes of the AMPA and NMDA components
of EPSCs were determined at 260 mV in the absence and presence of
NBQX (5–10 mM). The presence of residual Mg 21 did not affect the
kinetics of NMDA EPSCs recorded at 260 mV, because the kinetics
were in good agreement with those recorded at 1 40 mV in 1.0 mM
Mg 21-containing Ringer’s solution. For analyses and example traces in
Figures, the averages of four to eight single stimulations were used.
Ifenprodil (0.3, 3, or 10 mM; Sigma) reversibly reduced somatic NMDA
receptor currents. We used CP-101,606 (CP, 10 mM) in a concentration
known to selectively reduce NR2B-mediated NMDA receptor-mediated
currents in slices (Stocca and Vicini, 1998). The reduction of NMDA
EPSCs was only partially reversible even after 40 min of washout. CP did
not affect AMPA-mediated currents, which was tested in control exper-
iments. In both genotypes, AP5 (30 mM) completely blocked NMDA
EPSCs (data not shown).
Miniature EPSCs containing AMPA and NMDA components were
recorded at 270 mV in low Mg 21 Ringer’s solution (see above) contain-
ing additionally Ca 21 (4 mM final concentration) and TTX (1 mM;
Molecular Probes). Subsequently, AP5 (30–50 mM) was added to record
AMPA-only mEPSCs from the same cell. Recordings were analyzed
off-line (filtering, 2.9 kHz; sampling, 5 kHz) from 3 min sections using an
event detection program (kindly provided by Prof. Misgeld, Institute of
Physiology, University of Heidelberg). For event detection, trigger level
was set at approximately two to three times baseline noise, and false
positive events (e.g., artifacts or events overlapping in time) were ex-
cluded by subsequent raw data inspection. Rise time, peak, and decay of
averaged mEPSCs per 3 min section were analyzed, and frequencies
were calculated. The NMDA-only component was estimated by subtract-
ing the integral of the pharmacologically isolated AMPA mEPSC from
the integral of the total mEPSC. During 30 min recordings, the frequen-
cies of the mEPSCs reduced to the same extent in wild type and mutant
(data not shown). Miniature EPSCs were monoexponentially and biex-
ponentially fitted. The slow components of biexponential fits comprised
,25% in wild type and mutant, and they were not selectively affected by
AP5. Therefore, the effects on monoexponentially fitted mEPSCs are
presented.
Values are expressed as mean 6 SEM, and p values represent the
result of independent two-tailed t tests.
RESULTS
Reduced NR2A staining in hippocampal dendrites of
NR2AD C/ D C mice
To investigate the localization of NMDA receptors containing
the truncated NR2ADC subunit, we first compared by immuno-
cytochemistry the staining intensity (see Materials and Methods)
and distribution of NR2A in hippocampal cultures of wild-type
and NR2AD C/ D C mice. Cultured neurons from 18 mice were
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fluorescently labeled with an antibody against the N terminus of
the NR2A subunit and were imaged by confocal microscopy.
Examples of neuronal dendrites from wild-type and
NR2AD C/ D C mice are depicted in Figure 1A. Most wild-type
neurons had a large number of intensely NR2A-stained clusters
along the entire length of their dendrites. These clusters were
located in spines, as demonstrated by double-staining with an
antibody against the synaptic vesicle protein synapsin I (Fig. 1A,
panels 1–3). Most NR2AD C/ D C neurons had fewer intensely
NR2A-stained clusters ( panel 4), with the consequence that the
synapsin I staining dominated in the overlay ( panel 5). Because of
these characteristic differences, evaluators blinded to genotype
correctly classified seven out of nine wild-type and nine out of
nine NR2AD C/ D C cultures.
Cluster frequencies were quantified for 24 neurons from
NR2A-stained cultures (three mice per genotype), and 12 neu-
rons were stained with an NR2B antibody (five mice per geno-
type). The analysis was restricted to dendrites, and a total of 20.6
mm of wild-type and 20.8 mm of mutant dendrites were analyzed
for NR2A-stained clusters, and 16 mm of wild-type and 14 mm of
mutant dendrites were analyzed for NR2B-stained clusters. The
NR2A cluster frequency was reduced by 30% from 33 6 4
clusters per 100 mm dendrite (mean 6 SEM, n 5 12) in wild-type
neurons to 23 6 3 (n 5 12) in NR2AD C/ D C neurons ( p , 0.05)
(Fig. 1A), whereas the NR2B cluster frequency was similar in
wild-type (40 6 3, n 5 6) and NR2AD C/ D C neurons (39 6 3, n 5
6) (Fig. 1A). Thus, the cluster frequencies of NR2ADC-
containing NMDA receptors are reduced in dendrites of cultured
hippocampal neurons.
Reduced enrichment of NR2ADC in
postsynaptic densities
To elucidate whether the reduced amount of NR2ADC in hip-
pocampal cultures is caused by lower expression or altered sub-
cellular distribution, we compared the amount of NR2A in ho-
mogenates, synaptosomes, and PSDs, prepared from forebrains of
wild-type and NR2AD C/ D C mice (4–6 week old). Immunoblots
were analyzed with an antibody against the N terminus of NR2A
and with antibodies against NR2B and NR1 as controls.
In wild-type mice, NR2A, NR2B, and NR1 subunits were
Figure 1. Reduced synaptic enrichment of
NR2ADC protein. A, Immunocytochemistry
of primary hippocampal cultures (21 d in
vitro). Panels 1–3, Representative neuron from
wild-type mouse (WT ), double-stained for
anti-NR2A (1, green in 2) and anti-synapsin I
(3, red in 2); panels 4–6, representative neu-
ron from an NR2A D C/ D C mouse (DC/DC),
double-stained for anti-NR2A (4, green in 5)
and anti-synapsin I (6, red in 5); panels 7–9,
representative neuron from DC/DC mouse,
double-stained with anti-NR2B (7, green in 8)
and anti-synapsin I (9, red in 8). There are
fewer brightly stained spines opposite synap-
sin I-containing terminals in DC/DC neurons.
B, Immunoblots on postsynaptic densities
(PSD), synaptosomes (Syn), and homogenate
(Hom) from WT and DC/DC forebrains incu-
bated with NR2A, NR2B, or NR1 antibody.
Enrichment of full-length NR2A from Hom
to PSD was approximately four times more
efficient than that of truncated NR2A in
DC/DC mice. Also, the NR2ADC protein was
slightly reduced in the homogenate compared
with full-length NR2A. NR2B and NR1 were
similarly enriched in both genotypes; NR2B is
not upregulated in DC/DC. The arrows indi-
cate the WT 175 kDa and the truncated 100
kDa NR2A protein.
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enriched in synaptosomes and PSDs, when compared with their
levels in homogenates (Fig. 1B). The enrichment from homoge-
nate to PSD of NR2ADC in NR2AD C/ D C mice was approxi-
mately fourfold less than that of full-length NR2A in wild type,
but enrichment of NR2B and NR1 was not altered. We also
noticed slightly lower levels of NR2ADC in NR2AD C/ D C homog-
enates when compared with full-length NR2A in homogenates
from wild-type mice. The immunoblots did not detect a compen-
satory increase in the expression of NR2B (Fig. 1B).
Normal NR2ADC-containing NMDA receptor levels in
CA1 cell somata
To investigate whether somatic, i.e., extrasynaptic NMDA recep-
tors are reduced in NR2AD C/ D C mice, we activated pharmaco-
logically isolated NMDA receptor currents by fast application of
glutamate in nucleated whole-soma patches of CA1 pyramidal
neurons (Sather et al., 1992). Peak currents through NMDA
receptor channels were recorded at 240 mV in nucleated patches
of 12 wild-type and 7 NR2AD C/ D C mice (2 week old 5 P15) and
were 2196 6 25 pA (n 5 16) and 2254 6 56 pA (n 5 10),
respectively (Fig. 2A). To evaluate this difference, we related the
NMDA peak currents to pharmacologically isolated AMPA peak
currents, which were 21098 6 59 pA in wild-type (n 5 16) and
21206 6 98pA in NR2AD C/ D C mice (n 5 10). Hence, the ratio
of currents through NMDA and AMPA receptors was the same
in both genotypes (wild type, 0.18 6 0.02, n 5 16; NR2AD C/ D C,
0.2 6 0.03, n 5 10). Similar results were obtained at 280 mV
(data not shown), demonstrating comparable levels of functional
NMDA receptor channels in the somata of CA1 neurons of both
genotypes.
We used the NR2B-specific antagonist ifenprodil (Williams,
1993) to investigate the contribution of NR2B-containing recep-
tor channels to the somatic currents. Application of 3 mM ifen-
prodil reduced NMDA receptor-mediated peak currents by 48 6
3% in wild-type mice (n 5 5) and by 50 6 7% in NR2AD C/ D C
mice (n 5 3) (Fig. 2B). The similar effect of ifenprodil on peak
NMDA currents in wild-type and NR2AD C/ D C mice indicates a
similar somatic ratio of functional NR2A- and NR2B-type
NMDA receptors in the two genotypes.
The extent of desensitization during glutamate application in
NR2AD C/ D C mice provided additional proof for the presence of
NR2ADC-containing NMDA receptor channels. As determined
for recombinant receptors (Ko¨hr and Seeburg, 1996), NMDA
receptor currents desensitized faster in NR2AD C/ D C than in wild-
type mice, with time constants of 96 6 10 msec (mutant, n 5 13)
and 211 6 25 msec (wild type, n 5 17), respectively, when recorded
at 280 mV ( p , 0.001) (Fig. 2C). Accordingly, the second gluta-
mate response in a paired-pulse protocol was smaller in the mutant
because of slower recovery from desensitization (Fig. 2D).
Figure 2. Somatic NMDA receptor currents show
normal levels of functional NR2ADC-containing
receptors in DC/DC mice. A, Glutamate was fast-
applied for 10 msec to nucleated whole-soma
patches of P15 WT ( filled symbols) and P15
DC/DC mice (open symbols) in the presence of
AP5 to activate AMPA receptor currents (f/M) or
for 50 msec in the presence of NBQX and glycine
but in the absence of Mg 21 to activate NMDA
receptor currents (F/E) at 240 mV. The ampli-
tude ratio of NMDA/AMPA receptor currents
was comparable (right panel ). B, The NR2B-
specific antagonist ifenprodil (3 mM) reduced
NMDA receptor currents at 280 mV by ;50% in
both genotypes. C, NMDA receptor currents de-
sensitized faster (*p , 0.002) in DC/DC (E) than in
WT (F) during prolonged glutamate application
(400 msec; at 280 mV). Representative mutant
trace was enlarged by a factor of 1.25. D, Slower
recovery from desensitization in DC/DC mice (E,
*p , 0.006) compared with WT (F), investigated
by stimulation with two 50 msec glutamate pulses
(interpulse intervals: 0.1, 0.2, 0.3, 0.5, 1, 2, 3, 5, or
10 sec). Inset shows superimposed NMDA recep-
tor currents, activated at 280 mV with interpulse
intervals of 0.2 (1), 0.5 (2), 1 (3), and 2 sec (4).
Data were pooled (WT, n 5 7–10; DC/DC, n 5
4–6; n, number of investigated patches per inter-
pulse intervals) and fitted biexponentially (WT,
0.08 and 1.8 msec; DC/DC, 0.44 and 3.0 msec).
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Thus, comparable size and ifenprodil sensitivity but faster
desensitization of NMDA receptor currents in the mutant dem-
onstrate that NR2ADC-containing receptors contribute to the
somatic NMDA receptor population to the same extent as full-
length NR2A-containing receptors in wild type. Therefore, the
relatively small reduction in NR2ADC subunit levels revealed by
immunoblots of homogenates does not affect the number of
somatic NMDA receptors.
Smaller amplitudes of stimulus-evoked NMDA EPSCs
in NR2AD C/ D C mice
To determine whether the reduced synaptic enrichment of
NR2ADC protein as revealed by immunomethods affects NMDA
receptor-mediated currents at synaptic sites, we analyzed EPSCs
mediated by NMDA receptor channels (NMDA EPSCs) in CA1
pyramidal cells of wild-type and mutant mice (P15). Synaptic
EPSCs were evoked by stimulation of Schaffer collaterals in 0.1
mM Mg21 at 260 mV in the presence of the GABAA receptor
antagonist bicuculline (10 mM). The NMDA and AMPA compo-
nents of the EPSCs were determined in the presence and ab-
sence, respectively, of the AMPA receptor antagonist NBQX
(Fig. 3A). In both genotypes, NBQX blocked the fast EPSC
component mediated by AMPA receptors and also reduced the
late component of the EPSC caused by residual Mg21 block (0.1
mM), which was relieved as long as AMPA receptors were not
blocked. NMDA EPSCs were 2102 6 19 pA (n 5 8) in wild-type
slices but 249 6 6 pA (n 5 12) in mutant slices ( p , 0.05). The
AMPA components of EPSCs were 2192 6 34 pA (n 5 8) in
wild-type slices and 2135 6 18 pA (n 5 12) in mutant slices ( p 5
0.16). Thus, the ratio of NMDA to AMPA EPSCs was 0.55 6
0.05 in wild-type mice but 0.4 6 0.04 in NR2AD C/ D C mice (Fig.
3A). Hence, in P15 mutant mice, NMDA EPSC amplitudes were
reduced by 27%. In P30 mutants, the reduction reached 43% (Fig.
3A), consistent with less NR2B contribution in older animals
(Sans et al., 2000). In previous experiments (Sprengel et al.,
1998), this reduction was not observed, because the NMDA
component was determined in pharmacologically nonisolated
EPSCs 50 msec after the AMPA peak, and the slower deactiva-
tion kinetics of NMDA EPSCs (see below) implied larger ampli-
tudes in the mutant.
Thus, during evoked synaptic transmission, fewer NMDA re-
ceptors are activated in NR2AD C/ D C than wild-type mice.
Slower kinetics and delayed onset of stimulus-evoked
NMDA EPSCs in NR2A D C/ D C mice
After AMPA receptor blockade, we noticed slower rise and decay
times for the NMDA EPSCs in P15 and P30 NR2AD C/ D C mice
at 260 mV in 0.1 mM Mg21 and at 140 mV in 1 mM Mg21 ( p ,
0.001 for both) (Fig. 3, Table 1).
To determine whether the slower decay kinetics of NMDA
EPSCs in the mutant can be explained by an increased contribu-
tion of slower deactivating NR2B-containing receptors, given
that NR2ADC-containing receptors are reduced at synaptic sites,
we blocked NR2B-containing receptors with the ifenprodil deriv-
ative CP-101,606. In P15 NR2AD C/ D C mice, application of 10 mM
CP reduced NMDA EPSCs by 59 6 3% (n 5 9) and in wild-type
mice by 44 6 5% (n 5 9) ( p , 0.05) (Fig. 4A,B). An increased
synaptic contribution of NR2B-containing NMDA receptors in
NR2AD C/ D C mice was also demonstrated by more accelerated
decay time constants of the NMDA EPSCs after NR2B blockade
in P15 NR2AD C/ D C (from 295 6 14 to 172 6 9 msec, n 5 9, p ,
0.001) relative to wild-type mice (from 173 6 12 to 129 6 13
msec, n 5 9, p , 0.01) (Fig. 4B). The more pronounced effect of
CP on EPSC decay kinetics than on amplitudes in P15 mice
appears to derive from the lower peak open probability of NR2B-
than NR2A-containing receptor channels (Chen et al., 1999).
Consistent with increased synaptic NR2B contribution in the
mutant and the gradual postnatal decline in hippocampal NR2B
expression (Sans et al., 2000), CP accelerated NMDA EPSCs in
P15 and P30 mutants but only in P15 wild-type animals (Fig. 4B).
In P30 wild types, CP reduced the amplitudes of NMDA EPSCs
without accelerating the kinetics, possibly because of an increased
formation of NR1–NR2A and NR1–NR2A–NR2B receptor
channels. In the latter triheteromeric channels, the presence of
NR2A may result in fast-decaying NMDA EPSCs, and the pres-
ence of NR2B may explain the CP effect on amplitudes.
Surprisingly, after NR2B blockade by CP, the decay times of
NMDA EPSCs remained slower in mutant than wild type for
both age groups (Fig. 4B) (P15, p , 0.02; P30, p , 0.005), and CP
did not affect the significantly different rise times (Table 1). Thus,
Figure 3. Synaptically evoked NMDA EPSCs
have smaller amplitudes and slower kinetics in
DC/DC mice. A, EPSCs were evoked in bicucul-
line (10 mM), glycine (10 mM), and low Mg 21 (0.1
mM) at 260 mV in the absence or presence of
NBQX to determine the peaks of the AMPA
(f/M) or NMDA (F/E) components. The ampli-
tude ratio of NMDA/AMPA components (right
panel ) was decreased in P15 and P30 (*p , 0.02)
DC/DC mice, indicating reduced levels of synaptic
NMDA receptors in a developmentally progress-
ing manner. B, Superimposed NMDA EPSCs
evoked in bicuculline, glycine, and normal Mg 21
(1 mM) at 140 mV showing slower rise (see inset)
and decay time constants in P15 DC/DC (E) com-
pared with P15 WT (F). Mutant trace was en-
larged by a factor of 1.15. Rise and decay times of
all measurements are depicted in the right panels
(*p , 0.001). Consistent results were obtained at
260 mV in low Mg 21 (Table 1).
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NR2ADC contributes to the slower rise and decay times of
NMDA EPSCs in NR2AD C/ D C mice. Indeed, C-terminal trun-
cation could have affected affinity, gating, and/or the localization
of synaptic NR2ADC-containing receptors.
With regard to changes in affinity for glutamate, or in channel
gating, these are unlikely considering that C-terminal truncation
of NR2A subunits did not alter the rise (data not shown) and
decay kinetics of NMDA receptor currents either in HEK293
cells (Ko¨hr and Seeburg, 1996) or in the nucleated whole-soma
patches from area CA1 of the mutant mice. The rise time of
somatic NMDA currents was 4.8 6 0.2 msec (n 5 17) in wild-type
and 4.0 6 0.3 msec (n 5 13) in NR2AD C/ D C mice, and the decay
time constant for wild type was 66.9 6 2.8 msec (n 5 17) and
63.5 6 3.6 msec (n 5 13) for NR2AD C/ D C.
The slower kinetics of NR2ADC receptor-mediated NMDA
EPSCs may be better explained by a localization of NR2ADC-
containing NMDA receptors more distant from release sites in
the mutant compared with wild type, which should delay the onset
of NMDA EPSCs relative to AMPA EPSCs. Indeed, the interval
between onset of the AMPA and NMDA components was 1.1 6
0.2 msec (n 5 10) in P15 and 1.0 6 0.2 msec (n 5 8) in P30
wild-type mice, and 1.7 6 0.2 msec (n 5 10) in P15 and 1.5 6 0.1
msec (n 5 14) in P30 NR2AD C/ D C mice ( p , 0.05 for P15 and
P30 mice).
In summary, the slower rise and decay times of NMDA EPSCs,
which persisted after NR2B blockade, together with the delayed
onset of the NMDA component relative to the AMPA compo-
nent, indicate that NR2ADC-containing NMDA receptors ap-
pear to localize more distant from release sites than wild-type
receptors (see Discussion).
Strongly reduced NMDA component of mEPSCs
in NR2AD C/ D C mice
Further evidence for altered synaptic localization of NR2ADC-
containing NMDA receptors was obtained by recording mEPSCs,
given that glutamate released spontaneously in the absence of
action potentials should activate only AMPA and NMDA recep-
tors located close to active release sites (Yuste and Denk, 1995;
Mainen et al., 1999; Murthy et al., 2000).
mEPSCs in P15 NR2AD C/ D C and wild-type mice were re-
corded at 270 mV in TTX (1 mM), bicuculline (10 mM), glycine
(10 mM), and low Mg21 (0.1 mM). The AMPA component was
obtained in the presence of the NMDA receptor antagonist AP5.
As expected (McBain and Dingledine, 1992), AP5 reduced the
peak and blocked the late component of mEPSCs. The NMDA
component could not be isolated in the presence of NBQX,
because it was too small for detection, even at 140 mV in normal
Mg21 (1.0 mM). Therefore, the NMDA component was esti-
mated by subtracting the AMPA component from the total
mEPSC integral.
In both genotypes, mEPSCs with both AMPA and NMDA
components displayed comparable rise times and amplitudes (n 5
7 recordings each) (Fig. 5A, Table 2). The decay time course of
the mEPSC was slower in wild type because of a prominent
NMDA component that was absent in NR2AD C/ D C mice (Fig.
5A). Consistently, AP5 (30 mM)-mediated blockade of NMDA
receptors accelerated the decay of mEPSCs in wild type but not
in the mutant (Table 2). Indeed, in wild-type mice, the pharma-
cologically isolated AMPA mEPSCs decayed as fast as the mu-









WT P15 6.9 6 0.4 2125 6 14 126 6 10 260 27 (10)
P30 4.5 6 0.3## 2130 6 24 73 6 5# 260 8 (4)
DC/DC P15 9.1 6 0.6** 281 6 7* 243 6 16*** 260 35 (17)
P30 6.7 6 0.5***## 266 6 8 158 6 10*** 260 15 (5)
WT P15 5.7 6 0.2 145 6 16 171 6 9 140 15 (9)
DC/DC P15 7.7 6 0.3*** 116 6 12 292 6 11*** 140 19 (12)
Between genotypes: ***p , 0.001, **p , 0.005, *p , 0.05; within genotype (P15 vs P30): ##p , 0.005, #p , 0.05.
NMDA EPSCs were evoked in CA1 pyramidal cells by Schaffer collateral stimulation in bicuculline (10 mM), NBQX (10 mM), and glycine (10 mM) at 260 mV in 0.1 mM Mg 21
and at 140 mV in 1 mM Mg 21, in 2- and 4-week-old wild-type (WT) and NR2A DC/DC mice (P15 and P30). Values are mean 6 SEM. Numbers of recorded cells and analyzed
animals (in parentheses) are indicated. Statistical significance was weighted by a two-sample t test between wild-type and NR2A DC/DC mice (*) or between P15 and P30 within
one genotype (#).
Figure 4. Increased NR2B contribution to NMDA EPSCs in DC/DC
mice. A, The NR2B-specific antagonist CP 101,606 (CP, 10 mM) reduced
evoked NMDA EPSCs more (*p , 0.05) in P15 DC/DC than in P15 WT
and accelerated their deactivation time course (WT, control 222 msec, CP
161 msec; DC/DC, control 355 msec, CP, 190 msec). CP did not affect the
significantly different rise times (WT, 5.9 msec; DC/DC, 7.5 msec). B, CP
reduced amplitudes of evoked NMDA EPSCs more in DC/DC than WT
mice (lef t panel ), at P15 (*p , 0.05) and P30 ( p . 0.05). As expected
from the declining expression of NR2B during postnatal development,
CP accelerated the deactivation of NMDA EPSCs in WT mice at P15
(*p , 0.05; see Results) but not at P30 [control 92 6 8 msec (F), CP 86 6
5 msec (), n 5 11]. In contrast, CP accelerated the deactivation in
DC/DC mice at P15 (**p , 0.001; see Results) and at P30 [*p , 0.01,
DC/DC, control 177 6 13 msec (E), CP 125 6 9 msec; (), n 5 11],
consistent with increased NR2B contribution in the mutant. Notably, the
decay times remained slower in mutants than in wild types (P15, p , 0.02;
P30, p , 0.005). Results obtained at 140 mV (Mg 21, 1 mM) and at 260
mV (Mg 21, 0.1 mM) showed no significant difference and were pooled.
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tant mEPSCs recorded in control solution. The presence of a
small NMDA component in mutant mEPSCs was solely indicated
by an effect of AP5 on amplitude (Fig. 5A). The averaged integral
of the calculated NMDA component was more than twice as large
in wild type (0.14 6 0.024 pC; n 5 7) as in the mutant (0.063 6
0.019 pC; n 5 7) ( p , 0.05) (Table 2). Moreover, the ratio of
NMDA to AMPA integrals was 2.3 6 0.6 in wild-type and 0.7 6
0.2 in NR2AD C/ D C mice ( p , 0.005). Hence, the NMDA com-
ponent of mEPSCs is reduced in the mutant by 70%. The re-
maining NMDA component of mEPSCs was CP insensitive (data
not shown), suggesting that it was mediated mainly by NR2A-
containing receptors.
The NMDA component in P15 NR2AD C/ D C mice is thus
reduced more in mEPSCs (70%) than in evoked EPSCs (27%,
see above) but remains unchanged in nucleated patches, support-
ing the notion that NR2ADC-containing receptors are located,
on average, farther away from release sites than wild-type
receptors.
DISCUSSION
We asked in this study to what extent absence of the intracellular
C-terminal domain of the NR2A subunit impairs the contribu-
tion of NR2A-containing NMDA receptors to synaptic transmis-
sion in NR2AD C/ D C mice. We show by immunocytochemistry
that dendritic NR2ADC clusters are less frequent in cultured
hippocampal neurons from the mutant when compared with wild
type. Western blots prepared from mouse forebrain indicate that
steady-state levels of the NR2ADC subunit are lower in the
mutant relative to NR2A in wild type, and that the characteristic
high enrichment of NR2A in PSDs is not achieved in the mutant.
Electrophysiological studies reveal that NR2AD C/ D C mice have
normal NMDA currents in somata, somewhat reduced NMDA
components in evoked EPSCs, but drastically reduced NMDA
components in mEPSCs. Evoked NMDA EPSCs show a delayed
onset relative to AMPA EPSCs and have slower rise and decay
times. Thus, our data suggest that synaptic NR2ADC-containing
NMDA receptors are specifically reduced in number directly
under release sites and, in addition, are more distant from release
sites, on average, than full-length NR2A receptors in the vicinity
of release sites.
C-terminal truncation of NR2A did not affect somatic NMDA
receptor currents in mutant compared with wild type, except for
increased desensitization, consistent with the relatively small
reduction of NR2ADC in forebrain homogenates. However, the
amplitudes of evoked synaptic NMDA currents were reduced by
one-fourth (P15) to one-half (P30) in the mutant. This finding
and the substantial decline of the NMDA component of mEPSCs
by 70% is consistent with the drastically reduced enrichment of
NR2ADC in the PSD fraction. The apparent reduction of
NR2ADC at synaptic sites could be caused by impaired targeting,
transport, or anchoring of NR2ADC subunits to synaptic sites as
a consequence of C-terminal truncation (see also Sattler et al.,
2000). Our experiments cannot distinguish among these possibil-
ities. Nevertheless, NR2ADC still enriches in the PSD fraction,
although less than full-length NR2A, which may be attributed to
its association with the NR1 or NR2B subunits in heteromeric
receptors.
In addition to the reduction of NR2ADC at synaptic sites,
evoked NMDA EPSCs had a delayed onset relative to AMPA
EPSCs and rose and deactivated more slowly in mutant than wild
type. Perfusion of a NR2B-specific antagonist revealed an in-
creased NR2B contribution to NMDA EPSCs that was not com-
pensatory, because no evidence for an upregulation of NR2B
expression was found in immunoblots. However, after NR2B
blockade, NR2ADC-containing NMDA receptors themselves
must be responsible for the remaining slower NMDA EPSCs in
NR2ADC/DC mice. How can this finding be explained?
Although a slower recovery from desensitization may contrib-
ute to the slow deactivation of EPSCs (Lester and Jahr, 1992), it
cannot explain the slower rise times of NMDA EPSCs in
NR2AD C/ D C mice. Changes in affinity for glutamate or channel
gating could result in slower deactivation of NMDA EPSCs.
However, C-terminal truncation does not affect affinity for glu-
tamate or channel gating in general, because the deactivation of
NMDA currents in nucleated whole-soma patches was compara-
ble in wild type and mutant. Alternatively, full-length NR2A-
containing NMDA receptors may undergo a synapse-specific
arrangement to achieve a higher receptor packing density, which
might result in apparent higher agonist affinities of NMDA re-
ceptor channels, as previously seen for recombinantly expressed
glycine receptors (Taleb and Betz, 1994). This explanation seems
unlikely, however, because if C-terminal truncation prevents an
apparent increase in receptor affinity at synaptic sites, the NMDA
EPSCs in the mutant should decay more quickly, not more slowly,
than in wild type.
Our results are better explained by the following scenario (Fig.
6). Full-length NR2A-containing receptors, either as NR1-
NR2A or NR1-NR2A-NR2B hetero-oligomers, localize prefer-
entially close to release sites in PSDs. Truncation of the C termi-
nus of NR2A shifts the average localization of NR2ADC-
containing NMDA receptors so that they are less tightly linked to
release sites and to other PSD proteins, consistent with the
reduced enrichment of NR2ADC in the PSD fraction and the
delayed onset of NMDA EPSCs. This explanation relies on the
assumption that less glutamate accumulates in the synaptic cleft
when glutamate is released independently of action potentials
than when it is released by presynaptic stimulation. This assump-
tion seems justified because synaptic stimulation releases gluta-
mate simultaneously from many presynaptic terminals. In addi-
tion, glutamate is less efficiently cleared from the synaptic cleft in
our recordings at room temperature than in vivo, because gluta-
mate reuptake is temperature dependent (Bergles and Jahr,
1998). The different glutamate concentrations in the cleft associ-
ated with mEPSCs versus evoked EPSCs are reflected in the
slower decay kinetics of evoked EPSCs compared with mEPSCs
in our experiments (see also Burgard and Hablitz, 1993). We
Figure 5. NMDA components of miniature EPSCs are strongly reduced
in DC/DC mice. mEPSCs were recorded in TTX (1 mM), bicuculline (10
mM), glycine (10 mM), and low Mg 21 (0.1 mM) at 270 mV. mEPSCs had
comparable rise times and amplitudes, but their deactivation time course
was faster in DC/DC than in WT mice (see also Table 2). NMDA receptor
blockade (AP5) accelerated the deactivation only in WT and reduced the
amplitude in both genotypes. The calculated ratio of NMDA/AMPA
integrals (right panel ) was decreased in the mutant by 70% (*p , 0.005).
The current traces in control and AP5-containing solution are averages
(WT, n 5 158 and n 5 97; DC/DC, n 5 120 and n 5 32).
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hypothesize that action potential-independent glutamate release
activates only receptors within the PSD, thus resulting in the
strongly reduced NMDA component of mEPSCs in the mutant.
The higher glutamate concentrations produced by electrical stim-
ulation also activate the receptors localized outside the PSD.
Our schematic depiction may also apply to the situation early in
development when only NR2B-containing receptors are ex-
pressed in the CA1 synapse. Truncating the C terminus of NR2B
may also shift the localization of synaptic NR2BDC-containing
receptors toward positions more distant from release sites, be-
cause NMDA EPSCs are reduced to one-third in NR2BD C/ D C
mice, although the amount of NR2BDC protein is unchanged
compared with full-length NR2B in the wild type (Mori et al.,
1998). These data and our data both support the hypothesis that
the C termini of NR2 subunits are necessary for NMDA receptor
channels to achieve appropriate densities near release sites.
In adult NR2ADC/DC mice, hippocampal CA1 LTP is drasti-
cally reduced (Sprengel et al., 1998), which we initially explained
by hypothesizing that the missing C-terminal domain of NR2A in
the NMDA receptor precludes the assembly of constituents of
signal transduction pathways to monitor and appropriately pro-
cess the Ca21 transients elicited by NMDA receptor stimulation.
In the present study, we found that NMDA EPSC amplitudes
were reduced by ;50% in the NR2AD C/ D C mice (P30 mutants)
and that the activated NR2ADC-containing NMDA receptors
appear to be inappropriately localized. Thus, we propose that the
previously observed reduced level of LTP in NR2AD C/ D C mice is
caused in part by impaired synaptic localization of NR2ADC-
containing receptors.
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